{"id":781,"date":"2019-05-22T17:46:58","date_gmt":"2019-05-22T15:46:58","guid":{"rendered":"https:\/\/www.sacrocuore.it\/?page_id=781"},"modified":"2025-02-06T09:39:18","modified_gmt":"2025-02-06T08:39:18","slug":"radioterapia-aro-protocolli-di-studio-attivi","status":"publish","type":"page","link":"https:\/\/www.sacrocuore.it\/en\/servizi-di-diagnosi-e-cura\/radioterapia-oncologica\/radioterapia-aro-protocolli-di-studio-attivi\/","title":{"rendered":"Study protocols"},"content":{"rendered":"<p>The ARO Department is committed to several research programmes focused on high-precision radiotherapy treatments (IMRT, VMAT, IGRT, stereotactic radiotherapy), in particular for breast, cervicofacial and prostate cancers.<\/p>\n<p>Currently the active or soon active clinical protocols are:<\/p>\n<p>\u00b7\u00a0<strong><em>Studio di fase II sul trattamento del tumore prostatico rischio basso-intermedio &#8220;One Shot&#8221;<\/em><\/strong><strong>Principal investigator:<\/strong>\u00a0Prof. Filippo Alongi\u00a0<strong>Co-Investigator:<\/strong> Dr Niccol\u00f2 Giaj Levra, Dr Rosario Mazzola<\/p>\n<p>\u00b7\u00a0<strong>Studio Osservazione sul trattamento del microcitoma polmonare in malattia estesa. &#8220;TRENDS&#8221;<\/strong><strong>Principal investigator:<\/strong> Dr Niccol\u00f2 Giaj Levra<\/p>\n<p>\u00b7 <strong><em>Studio di fase II sul trattamento del tumore prostatico rischio basso-intermedio &#8220;One Shot&#8221;<\/em><\/strong> <strong>Principal investigator:<\/strong> Prof. Filippo Alongi <strong>Co-Investigator:<\/strong> Dr Niccol\u00f2 Giaj Levra, Dr Rosario Mazzola<\/p>\n<p>\u00b7 <strong>Studio Osservazione sul trattamento del microcitoma polmonare in malattia estesa. &#8220;TRENDS&#8221;<\/strong> <strong>Principal investigator:<\/strong> Dr Niccol\u00f2 Giaj Levra<\/p>\n<p>\u00b7 <strong>PRO-EPI-Studio Multicentrico Osservazionale PROspettico sull&#8217;Irradiazione Elettiva dei Linfonodi Pelvici (PRO-EPI) nei Pazienti con tumore della prostata a rischio intermedio\/alto\/molto alto, sottoposti a Radioterapia adiuvante o radicale con o senza concomitante associazione della Deprivazione Androgenica.<\/strong> <strong>Principal investigator:<\/strong> Prof. Filippo Alongi <strong>Co-Investigator:<\/strong> Rosario Mazzola, Niccol\u00f2 Giaj-Levra<\/p>\n<p>\u00b7 <strong>Studio di fase II sul trattamento delle oligometastasi epatiche e polmonari non operabili mediante radioterapia corporea stereotassica (SBRT) in pazienti con carcinoma mammario Trattamento radiante stereotassico per lesioni secondarie polmonari e\/o epatiche in pazienti affette da tumore mammario.<\/strong> <strong>Principal investigator:<\/strong> Prof. Filippo Alongi <strong>Co-Investigator:<\/strong> Rosario Mazzola, Dr Vanessa Figlia<\/p>\n<p>\u00b7 <strong>&#8220;A multicenter randomized trial to evaluate the efficacy of fentanyl pectin nasal spray (FPNS) versus Physician Choice (PC)- Usual Care (UC), in reducing incidental predictable breakthrough pain (IP-BTP) at swallowing in patients with head and neck cancer undergoing radiotherapy&#8221;<\/strong> <strong>Principal investigator:<\/strong> Dr Francesco Ricchetti, Dr Rosario Mazzola, Prof. Filippo Alongi <strong>Co-Investigator:<\/strong> Dr Francesco Ricchetti<\/p>\n<p>\u00b7 <strong>Studio randomizzato in pazienti affetti da tumore del distretto cervico-cefalico per la gestione del dolore alla deglutizione durante trattamento radiante.<\/strong> <strong>Principal investigator:<\/strong> Dr Rosario Mazzola <strong>Co-Investigator:<\/strong> Dr Francesco Ricchetti, Prof. Filippo Alongi<\/p>\n<p>\u00b7 <strong>Valutazione clinica e strumentale della disfagia tardiva in pazienti affetti da neoplasia del Rinofaringe e Orofaringe candidati a radiochemioterapia con modulazione di intensit\u00e0 modulata di dose (IMRT<\/strong><strong>)<\/strong> <strong>Principal investigator:<\/strong> Dr Rosario Mazzola <strong>Co-Investigator:<\/strong> Prof. Filippo Alongi, Dr Francesco Ricchetti<\/p>\n<p>\u00b7 <strong>A Randomized, double-blind, placebo-controlled Phase 3 study of JNJ-56021927 in subjects with high-risk localized or locally advanced prostate cancer receiving treatment with primary radiation therapy.<\/strong> <strong>Principal investigator:<\/strong> Prof. Filippo Alongi <strong>Co-Investigator:<\/strong> Dr Rosario Mazzola, Dr Niccol\u00f2 Giaj Levra<\/p>\n<p>\u00b7 <strong>A phase II randomized trial of Ablative Radiation Therapy in patients with Oligometastatic castration resistant prostate cancer (ARTO trial).<\/strong> <strong>Principal investigator:<\/strong> Prof. Filippo Alongi <strong>Co-Investigator:<\/strong> Dr Rosario Mazzola, Dr Niccol\u00f2 Giaj Levra<\/p>\n<p>\u00b7 <strong>Timing to minimally invasive surgery after neoadjuvant chemoradiotherapy for rectal cancer: a multiceter randomized controlled trial (TiMiSNAR)<\/strong> <strong>Principal investigator:<\/strong> Dott. Giacomo Ruffo <strong>Co-Investigator:<\/strong> Prof. Filippo Alongi, Dr Francesco Ricchetti<\/p>\n<p>\u00b7 <strong>Istituzione di un registro e studio osservazionale sull&#8217;applicazione clinica della metodica di Radioterapia Linac-based guidata da Risonanza Magnetica 1.5 Tesla (MRI-guided) con Unity\u00ae (CE, Elekta, Sweden).<\/strong> <strong>Principal investigator:<\/strong> Prof. Filippo Alongi <strong>Co-Investigator:<\/strong> Dr Rosario Mazzola, Dr Niccol\u00f2 Giaj Levra, Dr Michele Rigo<\/p>\n<p>\u00b7 <strong>E\u00b2-RADIatE: EORTC-ESTRO RADiotherapy InfrAstrucTure for Europe<\/strong> <strong>Principal investigator:<\/strong> Prof. Filippo Alongi <strong>Co-Investigator:<\/strong> Dr Niccol\u00f2 Giaj Levra, Dr Rosario Mazzola, Dr Luca Nicosia<\/p>\n<p>\u00b7 <strong>E\u00b2-RADIatE &#8211; OligoCare: A pragmatic observational cohort study to evaluate radical radiotherapy for oligo-metastatic cancer patients<\/strong> <strong>Principal investigator:<\/strong> Prof. Filippo Alongi <strong>Co-Investigator:<\/strong> Dr Rosario Mazzola, Dr\u00a0 Niccol\u00f2 Giaj Levra, Dr Michele Rigo<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The ARO Department is committed to several research programmes focused on high-precision radiotherapy treatments (IMRT, VMAT, IGRT, stereotactic radiotherapy), in [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"parent":767,"menu_order":40,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"class_list":["post-781","page","type-page","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.sacrocuore.it\/en\/wp-json\/wp\/v2\/pages\/781","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.sacrocuore.it\/en\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.sacrocuore.it\/en\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.sacrocuore.it\/en\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sacrocuore.it\/en\/wp-json\/wp\/v2\/comments?post=781"}],"version-history":[{"count":5,"href":"https:\/\/www.sacrocuore.it\/en\/wp-json\/wp\/v2\/pages\/781\/revisions"}],"predecessor-version":[{"id":151045,"href":"https:\/\/www.sacrocuore.it\/en\/wp-json\/wp\/v2\/pages\/781\/revisions\/151045"}],"up":[{"embeddable":true,"href":"https:\/\/www.sacrocuore.it\/en\/wp-json\/wp\/v2\/pages\/767"}],"wp:attachment":[{"href":"https:\/\/www.sacrocuore.it\/en\/wp-json\/wp\/v2\/media?parent=781"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}